Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response (2022)
- Authors:
- Autor USP: SOARES, IRENE DA SILVA - FCF
- Unidade: FCF
- DOI: 10.1371/journal.pntd.0010305
- Subjects: PLASMODIUM; ANTICORPOS; ANTÍGENOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2022
- Source:
- Título: PLOS Neglected Tropical Diseases
- ISSN: 1935-2735
- Volume/Número/Paginação/Ano: v. 16, n. 8, p. 1-22 art. e0010305, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DIAS, Michelle H. F et al. Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response. PLOS Neglected Tropical Diseases, v. 16, n. 8, p. 1-22 art. e0010305, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0010305. Acesso em: 28 jan. 2026. -
APA
Dias, M. H. F., Guimarães, L. F. F., Barcelos, M. G., Eduardo U. M. Moreira,, Nascimento, M. F. A. do, Souza, T. N. de, et al. (2022). Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response. PLOS Neglected Tropical Diseases, 16( 8), 1-22 art. e0010305. doi:10.1371/journal.pntd.0010305 -
NLM
Dias MHF, Guimarães LFF, Barcelos MG, Eduardo U. M. Moreira, Nascimento MFA do, Souza TN de, Pires CV, Monteiro TAF, Middeldorp JM, Soares I da S, Fontes CJF, Ntumngia FB, Adams JH, Kano FS, Carvalho LH. Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response [Internet]. PLOS Neglected Tropical Diseases. 2022 ; 16( 8): 1-22 art. e0010305.[citado 2026 jan. 28 ] Available from: https://doi.org/10.1371/journal.pntd.0010305 -
Vancouver
Dias MHF, Guimarães LFF, Barcelos MG, Eduardo U. M. Moreira, Nascimento MFA do, Souza TN de, Pires CV, Monteiro TAF, Middeldorp JM, Soares I da S, Fontes CJF, Ntumngia FB, Adams JH, Kano FS, Carvalho LH. Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response [Internet]. PLOS Neglected Tropical Diseases. 2022 ; 16( 8): 1-22 art. e0010305.[citado 2026 jan. 28 ] Available from: https://doi.org/10.1371/journal.pntd.0010305 - Resposta de anticorpos contra um antígeno recombinante derivado da proteína de ligação ao grupo sanguíneo Duffy expressa no merozoíta de Plasmodium vivax
- Serologically defined heterogeneity in P. vivax malaria transmission using a novel chimeric recombinant protein in riverine villages of the Peruvian Amazon
- A multianalyte Dot-ELISA for sumultaneous detection of malaria, Chagas disease, and syphilis-specific IgG antibodies
- Avidity IgG antibodies to P. vivax 'MSP1 IND. 19' recombinant antigen in vivax malaria patients
- Expression and purification of a recombinant protein based on domain II of Plasmodium vivax apical membrane antigen 1 fused to Salmonella Typhimurium flagellim (FliC)
- Immunogenicity of the Plasmodium vivax apical membrane antigen 1 (PvAMA-1): Comparison of homologous and heterologous prime-boost strategies using naked DNA and recombinant protein produced in Pichia pastoris
- A novel chimeric recombinant protein for the evaluation of serological responses in the Peruvian Amazonia
- Vacina contra malária te resultados promissores
- Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region
- Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: a nine year follow-up study in the Amazon region
Informações sobre o DOI: 10.1371/journal.pntd.0010305 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
